[Prescription, monitoring of antithrombotic treatment: 1--antiplatelet agents].
作者信息
Drouet Ludovic
机构信息
PU-PH, département d'angio-hématologie et clinique des anticoagulants Ile-de-France, hôpital Lariboisière, Paris Cedex.
出版信息
Rev Prat. 2007 Nov 30;57(18):2045-50.
PMID:18326440
Abstract
摘要
相似文献
1
[Prescription, monitoring of antithrombotic treatment: 1--antiplatelet agents].
Rev Prat. 2007 Nov 30;57(18):2045-50.
2
Antiplatelet agents and arterial thrombosis.抗血小板药物与动脉血栓形成
Cardiol Clin. 2008 May;26(2):189-201, vi. doi: 10.1016/j.ccl.2007.12.007.
3
Efficacy and safety of aspirin in the long-term management of atherothrombosis.阿司匹林在动脉粥样硬化血栓形成长期管理中的疗效与安全性。
Haematologica. 2002 Jan;87(1):6-8.
4
[Biological monitoring and prevention of complications from antithrombotic agents].[抗血栓药物的生物监测与并发症预防]
Arch Mal Coeur Vaiss. 1996 Nov;89(11 Suppl):1569-77.
5
GP IIb-IIIa inhibitors administered upstream: evidence for improved outcomes with conventional and newer antithrombotic agents?上游给予糖蛋白IIb-IIIa抑制剂：传统和新型抗血栓药物改善预后的证据？
Cardiol Rev. 2008 Mar-Apr;16(2):89-94. doi: 10.1097/CRD.0b013e31815e7213.
6
[A 100 years of aspirin: a drug with a future?].[阿司匹林百年：一种拥有未来的药物？]
An R Acad Nac Med (Madr). 1997;114(1):157-63; discussion 164-7.
7
[Recommendations for peri-procedural thrombocyte aggregation inhibition].[围手术期血小板聚集抑制的建议]
Dtsch Med Wochenschr. 2006 Feb 24;131(8):400-2. doi: 10.1055/s-2006-932534.
8
9
[Antiplatelet agents--problem for cardiac surgeon].[抗血小板药物——心脏外科医生面临的问题]
Kardiol Pol. 2006 Nov;64(11):1329-31.
10
Aspirin resistance: does it exist and is it an important clinical problem?阿司匹林抵抗：它是否存在，是否是一个重要的临床问题？
Clin Adv Hematol Oncol. 2006 Apr;4(4):268-70.
Zotero 插件